サマリー

世界のワクチン市場 2022-2026
Technavioはワクチン市場を監視しており、2022年から2026年の間に282億8000万ドルの成長が見込まれ、予測期間中にCAGR4.13％で加速しています。当レポートでは、ワクチン市場の全体分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新動向と推進要因、市場全体の環境について最新の分析を提供しています。市場は、ワクチン開発および新規ワクチン上市のための資金調達の増加、ワクチンの承認と強力なパイプライン、ワクチンにおけるアジュバントの使用増加によって牽引されています。
ワクチン市場の分析には、タイプ別セグメントと地域別の展望が含まれます。
Technavioのワクチン市場は以下のようにセグメント化されています。
タイプ別
- 予防用ワクチン
- 治療用ワクチン
地理的状況別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、ナノ粒子ワクチンの開発が、今後数年間のワクチン市場の成長を促進する主要な理由の1つであると特定しています。また、ワクチン送達システムの進歩やCOVID-19の影響により、市場におけるかなりの需要が見込まれます。
Technavioは、主要パラメータの分析による複数のソースからのデータの研究、合成、総括の方法によって、市場の詳細な図を提示します。ワクチン市場に関する弊社のレポートは、以下の分野を対象としています。
- ワクチン市場のサイジング
- ワクチン市場の予測
- ワクチン市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、アステラス製薬株式会社、AstraZeneca Plc、Bavarian Nordic AS、Bharat Biotech Ltd.、BrightPath Biotherapeutics Co.Ltd.、CSL Ltd.、第一三共 Co.Ltd.、Emergent BioSolutions Inc.、GlaxoSmithKline Plc、Gradalis Inc.、Inovio Pharmaceuticals Inc.、Johnson, and Johnson、Merck and Co.Inc.、三菱ケミカルホールディングス株式会社、Novavax Inc.、Pfizer Inc.、Sanofi、Serum Institute of India Pvt.Ltd.、Takeda Pharmaceutical Co.Ltd.、およびValneva SEです。また、ワクチン市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/vaccines-market-industry-size-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 Prophylactic vaccines - Market size and forecast 2021-2026
o Exhibit 28: Chart on Prophylactic vaccines - Market size and forecast 2021-2026 ($ billion)
o Exhibit 29: Data Table on Prophylactic vaccines - Market size and forecast 2021-2026 ($ billion)
o Exhibit 30: Chart on Prophylactic vaccines - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Prophylactic vaccines - Year-over-year growth 2021-2026 (%)
o 5.4 Therapeutic vaccines - Market size and forecast 2021-2026
o Exhibit 32: Chart on Therapeutic vaccines - Market size and forecast 2021-2026 ($ billion)
o Exhibit 33: Data Table on Therapeutic vaccines - Market size and forecast 2021-2026 ($ billion)
o Exhibit 34: Chart on Therapeutic vaccines - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Therapeutic vaccines - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Type
o Exhibit 36: Market opportunity by Type ($ billion)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ billion)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ billion)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ billion)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
o Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
o Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ billion)
o Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
o Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
o Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
o Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 France - Market size and forecast 2021-2026
o Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ billion)
o Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ billion)
o Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ billion)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Astellas Pharma Inc.
o Exhibit 85: Astellas Pharma Inc. - Overview
o Exhibit 86: Astellas Pharma Inc. - Product / Service
o Exhibit 87: Astellas Pharma Inc. - Key news
o Exhibit 88: Astellas Pharma Inc. - Key offerings
o 10.4 AstraZeneca Plc
o Exhibit 89: AstraZeneca Plc - Overview
o Exhibit 90: AstraZeneca Plc - Product / Service
o Exhibit 91: AstraZeneca Plc - Key news
o Exhibit 92: AstraZeneca Plc - Key offerings
o 10.5 Bavarian Nordic AS
o Exhibit 93: Bavarian Nordic AS - Overview
o Exhibit 94: Bavarian Nordic AS - Product / Service
o Exhibit 95: Bavarian Nordic AS - Key news
o Exhibit 96: Bavarian Nordic AS - Key offerings
o 10.6 Bharat Biotech Ltd.
o Exhibit 97: Bharat Biotech Ltd. - Overview
o Exhibit 98: Bharat Biotech Ltd. - Product / Service
o Exhibit 99: Bharat Biotech Ltd. - Key news
o Exhibit 100: Bharat Biotech Ltd. - Key offerings
o 10.7 BrightPath Biotherapeutics Co. Ltd.
o Exhibit 101: BrightPath Biotherapeutics Co. Ltd. - Overview
o Exhibit 102: BrightPath Biotherapeutics Co. Ltd. - Product / Service
o Exhibit 103: BrightPath Biotherapeutics Co. Ltd. - Key offerings
o 10.8 CSL Ltd.
o Exhibit 104: CSL Ltd. - Overview
o Exhibit 105: CSL Ltd. - Business segments
o Exhibit 106: CSL Ltd. - Key news
o Exhibit 107: CSL Ltd. - Key offerings
o Exhibit 108: CSL Ltd. - Segment focus
o 10.9 Daiichi Sankyo Co. Ltd.
o Exhibit 109: Daiichi Sankyo Co. Ltd. - Overview
o Exhibit 110: Daiichi Sankyo Co. Ltd. - Business segments
o Exhibit 111: Daiichi Sankyo Co. Ltd. - Key news
o Exhibit 112: Daiichi Sankyo Co. Ltd. - Key offerings
o Exhibit 113: Daiichi Sankyo Co. Ltd. - Segment focus
o 10.10 Emergent BioSolutions Inc.
o Exhibit 114: Emergent BioSolutions Inc. - Overview
o Exhibit 115: Emergent BioSolutions Inc. - Product / Service
o Exhibit 116: Emergent BioSolutions Inc. - Key news
o Exhibit 117: Emergent BioSolutions Inc. - Key offerings
o 10.11 GlaxoSmithKline Plc
o Exhibit 118: GlaxoSmithKline Plc - Overview
o Exhibit 119: GlaxoSmithKline Plc - Business segments
o Exhibit 120: GlaxoSmithKline Plc - Key news
o Exhibit 121: GlaxoSmithKline Plc - Key offerings
o Exhibit 122: GlaxoSmithKline Plc - Segment focus
o 10.12 Gradalis Inc.
o Exhibit 123: Gradalis Inc. - Overview
o Exhibit 124: Gradalis Inc. - Product / Service
o Exhibit 125: Gradalis Inc. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 126: Inclusions checklist
o Exhibit 127: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 128: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 129: Research methodology
o Exhibit 130: Validation techniques employed for market sizing
o Exhibit 131: Information sources
o 11.5 List of abbreviations
o Exhibit 132: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Prophylactic vaccines - Market size and forecast 2021-2026 ($ billion)
Exhibits29: Data Table on Prophylactic vaccines - Market size and forecast 2021-2026 ($ billion)
Exhibits30: Chart on Prophylactic vaccines - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Prophylactic vaccines - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Therapeutic vaccines - Market size and forecast 2021-2026 ($ billion)
Exhibits33: Data Table on Therapeutic vaccines - Market size and forecast 2021-2026 ($ billion)
Exhibits34: Chart on Therapeutic vaccines - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Therapeutic vaccines - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Type ($ billion)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ billion)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ billion)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ billion)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ billion)
Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on France - Market size and forecast 2021-2026 ($ billion)
Exhibits75: Data Table on France - Market size and forecast 2021-2026 ($ billion)
Exhibits76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ billion)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Astellas Pharma Inc. - Overview
Exhibits86: Astellas Pharma Inc. - Product / Service
Exhibits87: Astellas Pharma Inc. - Key news
Exhibits88: Astellas Pharma Inc. - Key offerings
Exhibits89: AstraZeneca Plc - Overview
Exhibits90: AstraZeneca Plc - Product / Service
Exhibits91: AstraZeneca Plc - Key news
Exhibits92: AstraZeneca Plc - Key offerings
Exhibits93: Bavarian Nordic AS - Overview
Exhibits94: Bavarian Nordic AS - Product / Service
Exhibits95: Bavarian Nordic AS - Key news
Exhibits96: Bavarian Nordic AS - Key offerings
Exhibits97: Bharat Biotech Ltd. - Overview
Exhibits98: Bharat Biotech Ltd. - Product / Service
Exhibits99: Bharat Biotech Ltd. - Key news
Exhibits100: Bharat Biotech Ltd. - Key offerings
Exhibits101: BrightPath Biotherapeutics Co. Ltd. - Overview
Exhibits102: BrightPath Biotherapeutics Co. Ltd. - Product / Service
Exhibits103: BrightPath Biotherapeutics Co. Ltd. - Key offerings
Exhibits104: CSL Ltd. - Overview
Exhibits105: CSL Ltd. - Business segments
Exhibits106: CSL Ltd. - Key news
Exhibits107: CSL Ltd. - Key offerings
Exhibits108: CSL Ltd. - Segment focus
Exhibits109: Daiichi Sankyo Co. Ltd. - Overview
Exhibits110: Daiichi Sankyo Co. Ltd. - Business segments
Exhibits111: Daiichi Sankyo Co. Ltd. - Key news
Exhibits112: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits113: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibits114: Emergent BioSolutions Inc. - Overview
Exhibits115: Emergent BioSolutions Inc. - Product / Service
Exhibits116: Emergent BioSolutions Inc. - Key news
Exhibits117: Emergent BioSolutions Inc. - Key offerings
Exhibits118: GlaxoSmithKline Plc - Overview
Exhibits119: GlaxoSmithKline Plc - Business segments
Exhibits120: GlaxoSmithKline Plc - Key news
Exhibits121: GlaxoSmithKline Plc - Key offerings
Exhibits122: GlaxoSmithKline Plc - Segment focus
Exhibits123: Gradalis Inc. - Overview
Exhibits124: Gradalis Inc. - Product / Service
Exhibits125: Gradalis Inc. - Key offerings
Exhibits126: Inclusions checklist
Exhibits127: Exclusions checklist
Exhibits128: Currency conversion rates for US$
Exhibits129: Research methodology
Exhibits130: Validation techniques employed for market sizing
Exhibits131: Information sources
Exhibits132: List of abbreviations